November 15th 2024
The algal EPA+DHA ingredient expands on the company's existing algal omega-3 portfolio which was DHA only.
GOED targets health practitioners with new omega-3 educational campaign
October 2nd 2018The Global Organization for EPA and DHA Omega-3s is making a push to spread awareness of omega-3s among healthcare professionals, including nurse practitioners, physician’s assistants, and pharmacists, with the launch of its new Fats for Life website.
Interaction between omega-3 fatty acids, statins for heart health explored in review
October 1st 2018The review found that the combination of omega-3s and statins for heart health can sometimes be complementary, but can also be antagonistic. The authors note that further intervention studies are needed to explore the interaction.
REDUCE-IT omega-3 study results show efficacy of EPA-only drug for heart disease
September 25th 2018Amarin Corp., maker of Vascepa, a high-concentration EPA-only omega-3 drug for heart health, published the topline results from its large-scale Reduction of Cardiovascular Events with EPA Intervention Trial (REDUCE-IT).
Omega-3 Cochrane meta-analysis is highly flawed, researcher writes
August 30th 2018Bill Harris, PhD, omega-3 researcher and founder of OmegaQuant, says a recent Cochrane report is biased because it ignores a large body of evidence showing favorable effects of EPA and DHA on cardiovascular risk.
High-protein, low-carbohydrate diet with omega-3 lowers blood glucose in animal study
July 26th 2018In the study, mice that were fed a high-protein, high-omega-3, low-carbohydrate diet exhibited lower blood glucose levels, including in induced type 1 diabetes, hormone-induced hyperglycemia, and diet-induced metabolic syndrome.
Fatty Fish Intake Cognitive Benefits Mostly Neutral in Preschool Children, Study Suggests
July 16th 2018In their main analysis, researchers found no significant cognitive benefits in Norwegian preschool students fed a fatty fish lunch versus a non-fish meat lunch for 16 weeks; however, they detected slight benefits in a sub-analysis adjusted for dietary compliance.
Omega-3 Compound Reduces Inflammation in Cystic Fibrosis Patients in New Pilot Study
July 2nd 2018In the pilot study, MaxSimil increased omega-3 red blood cell levels, moderated the ratio of arachidonic acid (AA) to docosahexaenoic acid (DHA), and reduced key inflammatory biomarkers in subjects with cystic fibrosis.
GOED's Ellen Schutt Discusses Omega-3 Market Challenges, Opportunities
May 18th 2018Nutritional Outlook recently spoke with Ellen Schutt, GOED’s new executive director, about how, under her leadership, the organization plans to identify market opportunities to move the omega-3 category forward.
DHA Fish Oil Concentrate May Support Immune Function in New Study
February 12th 2018Results from the pilot study showed that the high-DHA concentrate may indeed modulate human B-cell activity in middle-aged obese adults, but the study’s authors stressed the need for further testing in a larger cohort.
Industry Associations Respond to Meta-Analysis of Omega-3 and Heart Disease Research
February 5th 2018GOED issued a statement to its members affirming several points, including that the meta-analysis, which showed that omega-3 fatty acid supplementation had no significant associations with CHD death, nonfatal myocardial infarction, any coronary heart disease events, or major vascular events, adds little to the current body of evidence surrounding omega-3s and cardiovascular risk factors.